Literature DB >> 33068458

Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging-pathology study.

M Buciuc1, J R Duffy1, M M Machulda2, A J Spychalla3, J L Gunter3, C R Jack3, C Giannini4, A Raghunathan4, D W Dickson5, K A Josephs1, J L Whitwell3.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequent neuroimaging findings in patients with logopenic progressive aphasia (LPA), often with frontal lobe predilection. Cerebral amyloid angiopathy (CAA) is hypothesized to be the major pathologic determinant of MB/SS in these patients; however, neuroimaging-pathologic data are limited.
METHODS: All patients who had been prospectively recruited by the Neurodegenerative Research Group at the Mayo Clinic (Rochester, MN) between 2010 and 2015 and met the following inclusion criteria were included: (i) received an antemortem LPA diagnosis, (ii) had a gradient-recalled echo T2*-weighted magnetic resonance imaging (MRI) performed, (iii) died and completed a brain autopsy. Demographic, genetic, neuroimaging, and clinical and pathologic characteristics were compared between patients with/without MB/SS. Two-tailed Fisher exact and Wilcoxon rank sum tests were used for comparison of categorical and continuous variables, respectively.
RESULTS: Thirteen patients met inclusion criteria, six (46%) had MB/SS on MRI. Moderate/severe CAA was associated with the presence of MB/SS (p = 0.029). As expected, MB/SS most frequently involved the frontal lobes, followed by the parietal lobes. No clear associations were found between regional MB/SS distribution and regional distribution of CAA or hypometabolism on [18 F]-fluorodeoxyglucose-positron emission tomography. There was some evidence for a regional association between MB/SS and uptake on Pittsburgh compound B, although not in all patients. No formal statistical analyses to assess topographic relationships were performed due to the small sample size.
CONCLUSIONS: The presence of MB/SS is a strong indicator of underlying moderate/severe CAA in LPA, although the biological mechanisms underlying the topographic distribution of MB/SS remain unclear.
© 2020 European Academy of Neurology.

Entities:  

Keywords:  atypical Alzheimer’s disease; cerebral amyloid angiopathy; logopenic progressive aphasia; magnetic resonance imaging; microbleeds; positron emission tomography

Year:  2020        PMID: 33068458      PMCID: PMC8174551          DOI: 10.1111/ene.14594

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  17 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

3.  Microbleeds in the logopenic variant of primary progressive aphasia.

Authors:  Jennifer L Whitwell; Clifford R Jack; Joseph R Duffy; Edythe A Strand; Jeffrey L Gunter; Matthew L Senjem; Matthew C Murphy; Kejal Kantarci; Mary M Machulda; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2013-04-03       Impact factor: 21.566

4.  Association of Cerebral Microbleeds With Cognitive Decline and Dementia.

Authors:  Saloua Akoudad; Frank J Wolters; Anand Viswanathan; Renée F de Bruijn; Aad van der Lugt; Albert Hofman; Peter J Koudstaal; M Arfan Ikram; Meike W Vernooij
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

5.  White matter hyperintensities: relationship to amyloid and tau burden.

Authors:  Jonathan Graff-Radford; Eider M Arenaza-Urquijo; David S Knopman; Christopher G Schwarz; Robert D Brown; Alejandro A Rabinstein; Jeffrey L Gunter; Matthew L Senjem; Scott A Przybelski; Timothy Lesnick; Chadwick Ward; Michelle M Mielke; Val J Lowe; Ronald C Petersen; Walter K Kremers; Kejal Kantarci; Clifford R Jack; Prashanthi Vemuri
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

6.  Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging.

Authors:  Jonathan Graff-Radford; Timothy Lesnick; Alejandro A Rabinstein; Jeff Gunter; Jeremiah Aakre; Scott A Przybelski; Anthony J Spychalla; John Huston; Robert D Brown; Michelle M Mielke; Val J Lowe; David S Knopman; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri; Walter Kremers; Kejal Kantarci
Journal:  Neurology       Date:  2019-12-04       Impact factor: 9.910

7.  Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients.

Authors:  S-H Lee; J-M Park; S-J Kwon; H Kim; Y-H Kim; J-K Roh; B-W Yoon
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

8.  Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.

Authors:  Jennifer L Whitwell; Kejal Kantarci; Stephen D Weigand; Emily S Lundt; Jeffrey L Gunter; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Anthony J Spychalla; Daniel A Drubach; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.

Authors:  Matthew Schrag; Grant McAuley; Justine Pomakian; Arshad Jiffry; Spencer Tung; Claudius Mueller; Harry V Vinters; E Mark Haacke; Barbara Holshouser; Daniel Kido; Wolff M Kirsch
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088

10.  Focal hemosiderin deposits and β-amyloid load in the ADNI cohort.

Authors:  Kejal Kantarci; Jeffrey L Gunter; Nirubol Tosakulwong; Stephen D Weigand; Matthew S Senjem; Ronald C Petersen; Paul S Aisen; William J Jagust; Michael W Weiner; Clifford R Jack
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.